Skip to main content
. 2021 Jul-Aug;84(4):316–323. doi: 10.5935/0004-2749.20210045

Table 1.

Outcomes according to age at surgery (in months)

Parameter ≤9 months (n=22) 10-18 months (n=37) ≥19 months (n=34) p-value
Eyes, n (%) 22 (23.7) 37 (39.8) 34 (36.6) -
Laterality, n (%)
Unilateral
7 (31.8) 24 (64.9) 12 (35.3) 0.013*
Bilateral 15 (68.2) 13 (35.1) 22 (64.7)
Mean follow-up (months)
Median
54 72 61.5 0.085**
(IR) (30-75.3) (49.5-104) (33-86)
SE 1 month after surgery (D)
Mean ± SD
5.58 ± 2.77 3.26 ± 2.03 2.74 ± 1.45 0.000***
(Range) (0.50-9.75) (-1.50-8.00) (0.0-7.75)
SE at the final follow-up (D)
Mean ± SD
1.62 ± 4.05 -0.93 ± 2.77 -0.31 ± 2.68 0.000***
(Range) (-8.00-7.00) (-8.75-4.25) (-7.00-5.00)
CDVA (logMAR)
Mean ± SD
0.44 ± 0.29 0.59 ± 0.47 0.37 ± 0.37 0.085***
(Range) (0.1-1.1) (0.00-1.3) (0.00-1.3)
Myopic shift (D)
Mean ± SD
4.19 ± 2.86 3.64 ± 2.49 2.77 ± 2.00 0.092***
(Range) (0.50-9.75) (0.00-9.50) (0.00-7.00)
Postoperative complications, n (age in months)
VAO
5 (7, 8, 8, 9, 9) 6 (11, 11, 12, 16, 17, 17) 2 (24, 24) 0.109*
Corectopia 1 (8) 3 (10, 14, 16) 1 (22)
Pigments in IOL 0 2 (15, 16) 0
Fibrin formation 0 1 (17) 0
Strabismus (n, %) 9 (22.5%) 15 (37.5%) 16 (40%)
Additional surgeries**** (n, %) 6 (33.3%) 9 (50%) 3 (16.6%) 0.323*
*

Chi-squared test;

**

Kruskal-Wallis test;

***

ANOVA;

****

excluded strabismus surgeries.

SE= spherical equivalent; SD= standard deviation; CDVA= corrected distance visual acuity; D= diopter; n= number; IR= interquartile range; VAO= visual axis opacification; IOL= intraocular lens.